A Novel Series of Highly Potent Benzimidazole-Based Microsomal Triglyceride Transfer Protein Inhibitors-Reference-Cited by-同舟云学术

A Novel Series of Highly Potent Benzimidazole-Based Microsomal Triglyceride Transfer Protein Inhibitors

Published:2001-02-21 Issue:6 Volume:44 Page:851-856
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Robl Jeffrey A.¹,Sulsky Richard¹,Sun Chong-Qing¹,Simpkins Ligaya M.¹,Wang Tammy¹,Dickson John K.¹,Chen Ying¹,Magnin David R.¹,Taunk Prakash¹,Slusarchyk William A.¹,Biller Scott A.¹,Lan Shih-Jung¹,Connolly Fergal¹,Kunselman Lori K.¹,Sabrah Talal¹,Jamil Haris¹,Gordon David¹,Harrity Thomas W.¹,Wetterau John R.¹

Affiliation:

1. The Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm000494a

Reference7 articles.

1. Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994

2. Drug Treatment of Lipid Disorders

3. An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Bioactivity of Trifluoroethylthio-Substituted Phenylpyrazole Derivatives;Journal of Agricultural and Food Chemistry;2024-05-17

2. The Beneficial Effect of Lomitapide on the Cardiovascular System in LDLr−/− Mice with Obesity;Antioxidants;2023-06-16

3. Lomitapide ameliorates middle cerebral artery occlusion‐induced cerebral ischemia/reperfusion injury by promoting neuronal autophagy and inhibiting microglial migration;CNS Neuroscience & Therapeutics;2022-09-02

4. The microsomal triglyceride transfer protein inhibitor lomitapide improves vascular function in mice with obesity;Obesity;2022-03-06

5. Copper-catalyzed radical trifluoroethylthiolation of arylboronic acids with PhSO2SCH2CF3;Tetrahedron Letters;2021-08